Here Are the Next COVID Vaccines About to Cross the Finish Line

1 min read

Two coronavirus vaccines, one from Moderna (NASDAQ: MRNA) and one from Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX), have already gained authorization from the Food and Drug Administration. There are plenty of additional companies with vaccines looking to capture some of the market share.

In this video from Motley Fool Live recorded on Jan. 4, Corinne Cardina Jurney, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discuss the companies in late-stage development.

Continue reading

Leave a Reply

Your email address will not be published.

Previous Story

1 Red-Hot Healthcare Stock That Could Double Your Money

Next Story

Forget Alibaba, This Chinese Tech Stock is a Better Buy Right Now

Latest from Blog